Targeting the phosphoinositide-3 (PI3) kinase pathway in breast cancer.

The oncologist

Volumn 16 Suppl 1, Issue , 2011, Pages 12-19

  Baselga, José ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE;

BREAST TUMOR; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOLECULARLY TARGETED THERAPY; REVIEW; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; FEMALE; HUMANS; MOLECULAR TARGETED THERAPY; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION;

EID: 79959508436     PISSN: None     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-S1-12     Document Type: Review

References (0)